Floatz logo

Therapeutic Asset Ratings

414 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bdc-3042
Colorectal Cancer
Bolt Biotherapeutics, Inc.P1C (36)
bi 765063
Colorectal Cancer
Boehringer IngelheimP1C (36)
Bl-M17D1
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P1C (36)
Bpi-442096
Colorectal Cancer
Betta Pharmaceuticals Co., Ltd.P1C (36)
Budigalimab
Colorectal Cancer
AbbVieP1C (36)
Cadvec
Colorectal Cancer
Baylor College of MedicineP1C (36)
Cbi-1214
Colorectal Cancer
Cartography BiosciencesP1C (36)
Cea-Targeted Car-T
Colorectal Cancer
Weijia Fang, MDP1C (36)
Certepetide
Colorectal Cancer
University of California, San DiegoP1C (36)
Chimeric Antigen Receptor Modified T Cells Infusion
Colorectal Cancer
Shanghai Cell Therapy Group Co.,LtdP1C (36)
Clsp-5282
Colorectal Cancer
Clasp Therapeutics, Inc.P1C (36)
coq10
Colorectal Cancer
toqa saad mohammed mohammedP1C (36)
CRX100
Colorectal Cancer
BioEclipse TherapeuticsP1C (36)
ct-202
Colorectal Cancer
Context Therapeutics Inc.P1C (36)
ct-95
Colorectal Cancer
Context Therapeutics Inc.P1C (36)
Dat-2645
Colorectal Cancer
Danatlas Pharmaceuticals Co., LtdP1C (36)
Disp-10
Colorectal Cancer
Dispatch BiotherapeuticsP1C (36)
dk210
Colorectal Cancer
DEKA BiosciencesP1C (36)
Dp Cd8 Til
Colorectal Cancer
AgonOx, Inc.P1C (36)
Drug: Ibi3028
Colorectal Cancer
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.P1C (36)
Elvn-002
Colorectal Cancer
Enliven TherapeuticsP1C (36)
ft536
Colorectal Cancer
Fate TherapeuticsP1C (36)
ft836
Colorectal Cancer
Fate TherapeuticsP1C (36)
[Ga-68]-PNT6555
Colorectal Cancer
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and CompanyP1C (36)
gh21
Colorectal Cancer
Suzhou Genhouse Bio Co., Ltd.P1C (36)
Showing 276 to 300 of 414 assets
PreviousPage 12 of 17Next